Free Trial

Geode Capital Management LLC Sells 105,992 Shares of Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background

Geode Capital Management LLC trimmed its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 11.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 782,745 shares of the company's stock after selling 105,992 shares during the quarter. Geode Capital Management LLC owned about 1.71% of Azenta worth $39,149,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Picton Mahoney Asset Management lifted its position in Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after purchasing an additional 532 shares during the period. KBC Group NV boosted its position in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after acquiring an additional 698 shares in the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Azenta during the 4th quarter worth approximately $200,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Azenta by 14.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock valued at $225,000 after acquiring an additional 576 shares during the last quarter. Finally, Catalyst Funds Management Pty Ltd raised its position in Azenta by 123.0% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 4,684 shares of the company's stock valued at $234,000 after purchasing an additional 2,584 shares in the last quarter. 99.08% of the stock is owned by institutional investors and hedge funds.

Azenta Trading Down 1.0 %

AZTA traded down $0.25 during trading on Friday, reaching $25.25. 880,637 shares of the company's stock were exchanged, compared to its average volume of 637,738. Azenta, Inc. has a one year low of $24.68 and a one year high of $63.58. The firm has a fifty day moving average price of $37.36 and a two-hundred day moving average price of $44.15. The stock has a market capitalization of $1.15 billion, a PE ratio of -8.47 and a beta of 1.66.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Sell-side analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Evercore ISI lifted their price target on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research note on Thursday, February 6th. Needham & Company LLC boosted their target price on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research note on Thursday, February 6th. Stephens restated an "overweight" rating and issued a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd. Finally, TD Cowen upgraded shares of Azenta to a "hold" rating in a research report on Thursday, February 27th.

View Our Latest Stock Analysis on Azenta

About Azenta

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

See Also

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines